Shikonin as a WT1 Inhibitor Promotes Promyeloid Leukemia Cell Differentiation
Open Access
- 26 November 2022
- Vol. 27 (23) , 8264
Abstract
This study aims to observe the differentiating effect of shikonin on Wilms’ tumor 1 (WT1)-positive HL-60 cells and investigate the fate of the differentiated leukemia cells. WT1 overexpression unaffected cell viability but promoted resistance to H2O2-induced DNA injury and cell apoptosis. The binding of shikonin to the WT1 protein was confirmed by molecular docking and drug affinity reaction target stability (DARTS). Shikonin at the non-cytotoxic concentration could decrease the WT1 protein and simultaneously reduced the CD34 protein and increased the CD11b protein in a dose-dependent manner in normal HL-60 cells but not in WT1-overexpressed HL-60 cells. Shikonin unaffected HL-60 cell viability in 48 h. However, it lasted for 10 days; could attenuate cell proliferation, mitochondrial membrane potential (MMP), and self-renewal; prevent the cell cycle; promote cell apoptosis. In a mouse leukemia model, shikonin could decrease the WT1 protein to prevent leukemia development in a dose-dependent manner. In this study, we also confirmed preliminarily the protein–protein interactions between WT1 and CD34 in molecular docking and CO-IP assay. Our results suggest that: 1. shikonin can down-regulate the WT1 protein level for leukemia differentiation therapy, and 2. the interaction between WT1 and CD34 proteins may be responsible for granulocyte/monocyte immaturity in HL-60 cells.Keywords
Funding Information
- Youth Natural Science Foundation of Henan Province (212300410109)
- Youth Natural Science Foundation of Henan Province (82104697)
- Youth Natural Science Foundation of Henan Province (2021M690912)
- Youth Natural Science Foundation of Henan Province (SYL19060139-140)
- Youth Natural Science Foundation of Henan Province (SYL20060159-160)
- National Natural Science Foundation of China for Young Scholar (212300410109)
- National Natural Science Foundation of China for Young Scholar (82104697)
- National Natural Science Foundation of China for Young Scholar (2021M690912)
- National Natural Science Foundation of China for Young Scholar (SYL19060139-140)
- National Natural Science Foundation of China for Young Scholar (SYL20060159-160)
- China Postdoctoral Science Foundation (212300410109)
- China Postdoctoral Science Foundation (82104697)
- China Postdoctoral Science Foundation (2021M690912)
- China Postdoctoral Science Foundation (SYL19060139-140)
- China Postdoctoral Science Foundation (SYL20060159-160)
- Postgraduate education innovation and quality improvement project of Henan University (212300410109)
- Postgraduate education innovation and quality improvement project of Henan University (82104697)
- Postgraduate education innovation and quality improvement project of Henan University (2021M690912)
- Postgraduate education innovation and quality improvement project of Henan University (SYL19060139-140)
- Postgraduate education innovation and quality improvement project of Henan University (SYL20060159-160)
This publication has 57 references indexed in Scilit:
- Natural compounds and pharmaceuticals reprogram leukemia cell differentiation pathwaysBiotechnology Advances, 2015
- DNA Hydroxymethylation Profiling Reveals that WT1 Mutations Result in Loss of TET2 Function in Acute Myeloid LeukemiaCell Reports, 2014
- Concise Review: Evidence for CD34 as a Common Marker for Diverse ProgenitorsStem Cells, 2014
- WT1 vaccination in acute myeloid leukemia: new methods of implementing adoptive immunotherapyExpert Opinion on Investigational Drugs, 2013
- Induction of apoptosis of leukemic cells by TRUE gene silencing using small guide RNAs targeting the WT1 mRNALeukemia Research, 2013
- Molecular Interaction Studies Using Microscale ThermophoresisASSAY and Drug Development Technologies, 2011
- Target identification using drug affinity responsive target stability (DARTS)Proceedings of the National Academy of Sciences, 2009
- Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patientsLeukemia, 2002
- Physical Interaction between Wilms Tumor 1 and p73 Proteins Modulates Their FunctionsJournal of Biological Chemistry, 2000
- Wilms' Tumor Gene Product WT1 Arrests Macrophage Differentiation of HL-60 Cells Through Its Zinc-Finger DomainBiochemical and Biophysical Research Communications, 1999